Transaction · 0001610717-26-000003

Saxonov Serge

Saxonov Serge, CEO, reported a transaction classified as exercise at 10x Genomics, Inc. involving 32537.000000 shares for an estimated $0.00. Reported holdings after the transaction were 173600.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

exerciseSEC transaction code MCEO
TXG10x Genomics, Inc.
Filing timeJan 07
Trade dateJan 05, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
…
Pre-filing
…
Returns since
…

TXG price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
TXG since 2026-01-07Filed 240 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
exercise
Code M
Identifier
0001610717-26-000003
Stock Option (right to buy)
Transaction date
Jan 05, 2026
Filed Jan 07, 2026, 09:52 PM · 2d delay
Shares
32.5k sh
$0 per share
Estimated value
$0
Computed from shares × price
Holdings after
173k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Derivative Transaction Direct Ownership
-6score
Filing-only score

-6

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Executive Officer

Officer YesDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    The shares are held by the Andromeda Trust, for which the Reporting Person serves as trustee.

  2. F2

    The shares are held by the Y/S Descendants' Trust, for which the Reporting Person serves as trustee.

  3. F3

    The shares are held by the Y/S Pot Trust, for which the Reporting Person serves as trustee.

  4. F4

    All of the shares subject to the option are fully vested and exercisable as of the date hereof.

Original filing · 0001610717-26-000003
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

TXG